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Summary: The phosphorylation of ribosomal proteins in rat liver injured for various times by carbon tetrachloride
and extrahepatic cholestasis was studied. The incorporation of [32P]phosphate into the protein moiety of the small
ribosomal subunit was increased over 2-fold 1 to 4 h after injection of the hepatotoxin, whereas the specific activity
of the 60 S subunit was low and changed only insignificantly. Two-dimensional electrophoretic analysis of ribosomal
proteins complemented by autoradiography revealed that CC14 stimulated the phosphorylation of only a single
protein (S6) in the 40 S subunit. The phosphorylation of S6 led to a measurable anodic shift and elongation of the
protein on the 2-dimensional electropherograms.
In response to bile duct ligation a similar increase in phosphorylation of protein S6 was noticed.
Ribosomale Proteinmodifikationen bei Leberschädigungen:
Einfluß von Tetrachlorkohlenstoff und extrahepatischer Cholestase auf die Proteinphosphorylierung
Zusammenfassung: Die Phosphorylierung ribosomaler Proteine in der Rattenleber, die unterschiedlich lang durch
Tetrachlorkohlenstoff und extrahepatische Cholestase geschädigt worden war, wurde untersucht. Die Inkorporation
von [32P]phpsphat in den Prpteinanteil der kleinen ribosomalen Untereinheit war über 2fach erhöht l bis 4 Stunden
nach Gabe des Hepatotoxins, wohingegen die spezifische Aktivität der 60S Untereinheit niedrig war und sich nur
unbedeutend änderte. Zwei-dimensionale Elektrophoresen ribosomaler Proteine, ergänzt durch Autoradiographie,
zeigten, daß CC14 die Phosphorylierung nur eines Proteins (S6) in der 40 S Subfraktion stimulierte. Die Phosphorylie-
rung von S6 führte zu einer meßbaren anodischen Verlagerung und Elongation dieses Proteins auf den 2-dimensionalen
Elektropherogrammen.
Eine Ligatur des Gallenganges führte zu einem vergleichbaren Anstieg der Phosphorylierung von Protein S6.
Introduction
General subcellular reactions to toxic liver cell injury
are disruption of the rough endoplasrriic reticulum,
disaggregation of polyribosomes into monomers,
detachment of the ribosomes from the membrane and
a reduction in the number of ribosomes per cell (1).
These ultrastructural changes are associated with
impaired synthesis of both liver and exported hepato-
genie proteins. By introduction of high-resolution
electrophoresis (2, 3), affinity labeling (4, 5), lacto-
peroxidase ipdination (6, 7) and reductive alkylation
(4, 8, 9) of liver ribosomal proteins it became possible
to extend the examination of ribosomal pathology to
the molecular level (10). Studies employing these
techniques revealed profound alterriation.s of ribosomal
conformation (9) and reversible chemical modifications
of specific ribosomal proteins (11,12) during altered
liver metabolism. Structural variations of this kind
and modulation of ribosomal activity are interrelated
(4,13).
It has been shown that the state of phosphorylation of
protein S6 from the small ribosomal subunit of liver
ribosomes (S6 is the major phosphorylated site in
normal eukaryote ribosomes (11,14—16)), is signifi-
cantly enhanced when the liver is injured by toxic agents
(17). However, the degree of phosphorylation, and the
number and identity of phosphorylated ribosomal
proteins in carbon tetrachloride damaged livers have
not been investigated so far. In addition to this widely
used model of drug-induced liver damage, we have
studied the phosphorylation of protein S6 in response
to experimental bile-duct obstruction. The latter disease
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was chosen since it resembles more closely human liver
pathology and involves changes of cellular protein
synthesis which are quite different from those observed
in CCl4-evoked liver disease (18).
Materials and Methods
Treatment of rats
Male Sprague-Dawley rats (220-260 g body weight, Zentralinsti-
tut f r Versuchstiere, Hannover, FRG) received standard rat diet
and water ad libitum.
Between 8.00 and 11.00 a. m. the animals were injected sub-
cutaneously (back skin) with CC14 (Merck, Darmstadt, FRG),
2.5 ml/kg body weight, freshly dissolved in paraffinum liquidum
(volumes, 50 ml + 25 ml). Control rats received a similar volume
of paraffinum alone. 1, 2, and 4 h later the rats were injected
intraperitoneally with 37 MBq = 1 mCi [32PJo-phosphoric acid
(carrierfree, New England Nuclear Corp., Boston, USA) and
sacrificed 30 min thereafter.
Ligation of the common bile duct was performed under light
ether anesthesia. The bile duct was dissected from surrounding
structures and two silk ligatures were passed behind the common
duct just distal to the junction of the hepatic ducts. Sham
operated rats were treated identically but the ligation was
omitted. 1, 2, and 3 days after operation the animals were
decapitated, blood was collected from the neck vessels and non-
hemolytic serum prepared.
Isolation of liver ribosomes, ribosomal subunits and
ribosomal protein
Livers were quickly removed, chilled in ice-cold buffer
(0.05 mol/1 Tris-HCl, pH 7.6 at 20 °C, 0.08 mol/1 KC1,
0.0125 mol/1 MgCl2) and ribosomes (19) and ribosomal sub-
units (20) „were prepared. Ribosomes from cholestatic livers
were isolated in buffer containing 0.1 mmol/1 L-p-bromotetra-
misole oxalate (Aldrich Chemical Comp., Milwaukee, USA)
which acts as a stereospecific, noncompetitive inhibitor of
alkaline phosphatase (21, 22). The concentration used inhibited
the activity of the enzyme in total liver homogenate by 86%.
Ribosomal proteins were extracted from subunits with acetic
acid (23, 24) and their concentrations were determined (25)
using bovine serum albumin as a standard. The specific radio-
activity of the microsomes, of the ribosomal particles (counts/
roin ' ^260 unit) an(* °f ribosomal protein (counts/min · //g
protein) were measured as described (11).
Two-dimensional poly aery lamide gel electrophoresis and
autoradiography of ribosomal proteins
About 540 Mg and 630 Mg of ribosomal proteins extracted from
the 40 S and 60 S subunit, respectively, were separated by two-
dimensional electrophoresis on small polyacrylamide gel slabs
(11). For autoradiography the dried gels were exposed for
14 days to Kodak Kodirex X-ray film. To determine the radio-
activity comigrating with protein S6 the area of protein S6 was
excised from the gel, sliced in 1 mm strips, digested (26) and
counted as described (11).
Ribosomal proteins were enumerated according to the nomen-
clature ofSherton & Wool (27).
For estimation of the phosphorylation state of protein S6 in
injured liver as visualized on the electropherograms, the elonga-
tion angle (e°) and the area of phosphorylated S6 (ap) were
calculated (fig. 2F). A vertical line was constructed through the
center of protein S4 and the area of S6 located anodically from
this line was measured with transparent mm-paper. The elonga-
tion angle is defined as the angle between the vertical line crossing
the center of S4 and the line touching the most anodic part of
stained protein S6.
Determination of bilirubin concentration and enzyme activities
in serum
To verify the effectiveness of the ligation of the ductus chole-
dochus, serum was analysed with a DuPont Automatic Clinical
Analyzer for total bilirubin concentration (28) and with an Ep-
pendorf enzyme automate 5020 for the activities of alanine
aminotransferase (EC 2.6.1.2) (29), aspartate aminotransferase
(EC 2.6.1.1) (30), alkaline phosphatase (EC 3.1.3.1) (31), and
leucine arylamidase (EC 3.4.1.1) (32).
Results
Carbon tetrachloride induced liver injury
The incorporation of [32P]phosphate into liver micro-
somes and crude ribosomal particles was stimulated 1.5-
and 1.8-fold above normal at one hour after administra-
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Fig.. 1. The effect of carbon tetrachloride on the incorporation of
[3iP]phosphate into microsomes and ribosomal components
of liver.
Rats were injected s. c. with CC14 (2.5 πύ/kg body weight)
and received i. p. 1, 2 and 4 h later ImCi [32P]orthophos-
β phoric acid 30 ήϊίη before sacrifice. The particles were8
 isolated from liver and their specific radioactivity
(counts/min' · A26o) determined (a, · · microsomes,
·-—· 80 S ribosomes: b, · · 40 S, ^—* ft S). In c
the specific activity of ribosomal protein (· · 40 S,
A-—A 60 S) is given. The values are the mean ± S. D. of
4 separate experiments.
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tion of CC14 but decreased to nearly control values 2
and 4 h later (fig. la). After purification and separation
of ribosomal subunits in high ionic strength buffer a
2.4-fold enhancement of the incorporation of the iso-
tope into the 40 S subunit (100 counts/min - E26o) at
2 h after application of the hepatotoxin was noted
(fig. Ib). The specific radioactivity of the 60 S fraction,
however, was rather low (7 counts/min · A26o) m&
increased only inconsistently during the treatment. The
[32P]phosphate content of ribosomal proteins extracted
from the small subunit was doubled 1 to 4 h'after injec-
tion of CC14; the specific activity of the protein of the
60 S subunit reached a maximum increase at l h after
onset of treatment (fig. Ic).
To study the number and location of ribosomal phos-
phoproteins the 40 S subunit proteins isolated from
CC14-injured liver were analysed by 2-dimehsional gel
electrophoresis and autoradiography. Figure 2a demon-
strates the pattern of 40 S ribosomal proteins derived
from control rat liver in which protein S6 was identified
as the only radioactive (32P-containing) protein (fig. 3a).
Under the influence of CC14 no additional phospho-
protein was detectable, thus the enhancement of
phosphorylation of the 40 S subunits was strictly con-
fined to protein S6 (fig. 3b). The increase in negative
charge of this protein affected its position and shape
on two-dimensional electropherograms (fig. 2c—e). It
can be seen that as early as one hour after initiation of
liver injury the elongation angle (e°) and the area (ap) of
phosphqrylated S6 were greatly enhanced and increased
further 2 and 4 h later (fig. 2f-i). No other protein
showed similar changes in its electrophoretic mobility.
By treatment of 40 S subunits from CCl4-injured liver
with alkaline phosphatase prior to electrophoresis the
anodic shift of S6 could be completely reversed (not
shown). Figure 4 shows the distribution of radioactivity
in protein S6 from normal and CCl4-treated liver. It is
evident that liver damage for 2 and 4 h results in a
strong increase in the number of phosphorylated amino
acid residues of S6; the peak activity was located in the
anodic part of the protein.
As judged from the electropherograms none of the
proteins of the large ribosomal subunit was modified in
CC14-intoxicated rat liver (fig. 5).
Extrahepatic cholestasis
Occlusion of the common bile duct led to a progressive
increase in the concentration of total bilirubin and
leucine arylamidase activity in serum (tab. 1). The
activities of alkaline phosphatase, alanine aminotransfer-
ase and aspartate aminotransferase were highest 1 day
after operation but decreased sharply thereafter.
By comparison of the electropherograms of the small
ribosomal subunit proteins from bile-duct ligated and
sham-operated rat liver, a reduced electric mobility of
protein S6 in both dimensions became visible; this
clearly indicates an elevated level of phosphorylation
of the protein in cholestatic liver disease (fig. 6). The
elongation angle and the area of phosphorylated S6
were increased 3- and 7-fold, respectively, in response
to bile duct obstruction (tab. 2).
The electropherograms did not show any other protein
of the small and large ribosomal subunit (not shown) to
be affected in a similar way by the operation.
V
S2
oi\\ b I
QP:37
Fig. 2. Two dimensional electrophoresis of liver 40 S ribosomal proteins from normal and CCl4-treated rats.
a represents the protein pattern of 40 S subunits from control liver. The encircled region containing the proteins S 2 to S 7
is presented schematically in b. In c, d, e this region is shown from rats treated for 1, 2 und 4 h, respectively, with CC14. In f ^
the elongation angle (e°) and the dotted area (ap) of phosphorylated protein S 6 (S 6p) as defined in "materials and methods
are indicated, g, h, i are schemes of c, d, e, respectively, in which e° and ap (mm2) were calculated.
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Fig. 3. Autoradiographs of 40 S-derived ribosomal proteins
from normal liver (a) and liver treated for 2 h with
CC14 (b). Details are described in figure 1. Protein of
the 40 S ribosomal subunit was separated by 2-dimensio-
nal electrophoresis and the dried gels were exposed to
X-ray film.
Fig. 5. Two-dimensional electropherograms of ribosomal
proteins of the 60 S subunit isolated from the livers
of control rats (a) and animals treated for 4 h with
CC14 (b). Details are described in figure 1.
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Fig. 4. The effect of CCl4-treatment on the distribution of
[32P] activity in liver ribosomal protein S 6. Rats
were pretreated as described in figure 1. Protein S 6
separated by 2-dimensional electrophoresis was
excised from the gel, sliced from anode to cathode
in 2 mm strips and counted for radioactivity. S 6
from control (· n), l h (CD—a), 2 h (· ·) and
4 h (A A) CCl4-exposed liver is shown.
Fig. 6. Sections containing proteins S 2 to S 7 of the two-
dimensional electropherograms of 40 S ribosomal
proteins from sham-operated (a, b, c) and bile duct
ligated (d, e, f) rat liver one day (a, d), two days
(b, e) and three days (c, f) after operation. A vertical
line was constructed through the center of protein
S 4 to measure the elongation angle (e0) and the area
(ap) of S 6 p as described in figure 2.
Tab. 1. Concentration of total bilirubin and activities of alkaline phosphatase, leucine arylamidase, alanine aminotransferase and
aspartate aminotransferase in serum of sham-operated and bile duct ligated rats l·, 2 and 3 days after operation.
Treatment of rats
Sham-operated
Bile duct ligated
Iday
2 days
3 days
Total bilirubin
(μηιοΐ/ΐ)
3.6 ± 0.34
59.2 ± 2.7
93.4 ± 9.7
120.2 ± 5.6
Alkaline
phosphatase
(U/l)
230 ± 45
1340 ±270
918 ± 100
717 ± 6
Leucine
arylamidase
(U/l)
22 ± 3.2
37 ± 1.1
41 ± 9.7
45 ± 5.0
Alanine
aminotransferase
(U/l)
36 ± 5.2
256 ± 124
230 ± 88.
59 ± 25
Aspartate
aminotransferase
(U/l)
113 ± 23
476 ± 132
322 ±180
164 ± 44
The values are the mean ± S. D. of 4 to 6 separate experiments.
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Tab. 2. The effect of extrahepatic cholestasis on the phosphoryla-
tion of ribosomal protein S 6.
1, 2 and 3 days after bile duct ligation ribosomal pro-
teins of the 40 S subunit were isolated and separated by
two-dimensional electrophoresis. Elongation angle (e°)
and the area of phosphorylated S 6 (~ S 6p) were calcu-
lated from the electropherograms (fig. 6d, e, f) as defined
in "Materials and Methods". The values are the mean ± S. D.
of 3-4 experiments.
Treatments of rats
Sham -operated
Bile duct ligated
Iday
2 days
3 days
Elongation angle
<e°)
28 ± 5
73 ±10
75 * 8
77 ± 9
Area of
phosphorylated
S6
(mm2)
4± 2
18 ±4
29 ±4
15 ± 3
Discussion
As evidenced by incorporation studies of [32P]phos-
phate into ribosomal proteins and 2-dimensional
electrophoresis complemented by autoradiography,
CC14-evoked liver damage is associated with an enhanced
phosphorylation of protein 56 of the small ribosomal
subunit. The specific radioactivity of the 60 S particle
was low and changed inconsistently during liver damage.
The variation might be attributed to a contamination of
the large subfraction with small amounts of phosphor-
ylated 40 S subunits (11) rather than to a disease-
initiated increase in the phosphorylation state of the
acidic phosphoproteins discovered recently in the 60 S
subunit (33-38),
The protein modification occurs early after onset of
damage, however, the interindividual variation in the
rate of isotope incorporation was relatively high in the
initial phase (about 50%) in comparison to later stages
of liver injury (about 25%) (fig. 1). This is explained by
a variable absorption of the drug from subcutaneous
tissue. The more common way of administration of
CC14 via stomach tube was avoided since a prolonged
starvation period and manipulation of the rat by intuba-
tion prior to the experiment changes the phosphorylation
of S6 in an unspecific and non-reproducible manner,
resulting mainly from increased circulating levels of
adrenalin (39),
An enhanced degree of phosphorylation of S6 was also
seen in galaQtosamme-(40), dimethylnitrosamine-(41)
and thioacetamide-(42) induced liver injury. Recovery
from ethionine-generated inhibition of liver protein
synthesis by treatment with adenine also leads to ex-
tensive phosphorylation of S6 (39).
It is remarkable that obstructive jaundice, a quite differ
ent type of experimental liver disease, produces chemical
modifications of S6 similar to those in toxic liver injury.
Taken together, the results suggest an unspecific
mechanism of ribosomal protein phosphorylation, which
is common for the various modes of liver injury. The
state of phosphorylation of S6 was monitored by calcula-
tion of the elongation angle and the area of phosphoryl-
ated protein S6 seen on the 2-dimensional electrophero-
grams. The elongation angle indicates the maximum
anodic shift of the protein and hence the highest phos-
phorylated (negatively charged) variant of S6. The
phosphorylated area reflects roughly the relative amount
of the modified part (S6p) of protein S6. The method
might be too insensitive to detect low levels of phos-
phorylation of protein S6, but electrophoretic visualiza-
tion and quantitation of S6p circumvents the problems
inherent in studies using labeled precursors, providing
special care is taken to avoid possible dephosphorylation
during the preparation of the particles. Thus the use of
levamisole and its analogs, which are potent, stereo-
specific and non-competitive inhibitors of alkaline
phosphatase (2.1, 22), is a prerequisite for the isolation
of 40 S subunits in a high phosphorylated state from
cholestatic liver tissue.
The functional role of protein S6 and of its phosphoryl-
ated isoproteins are hitherto unknown. As shown in the
present study elevated phosphorylation occurs in types
of liver disease which have contrary effects on hepatic
protein synthesis. Carbon tetrachloride causes an
immediate and dose-dependent depression of amino
acid polymerization (43—45) accompanied by poly-
some breakdown (46—48) and impaired activity of the
ribosome per se (49). The latter might be a consequence
of irreversible binding of the activated metabolite
CC13* (50) to ribosomal components (47). In cholestatic
liver, induced either by biliary obstruction (51, 52) or
application of α-naphthylisothiocyanate (ANIT) to rats
(53, 54), an increased rate of protein synthesis was
found. Thus enhanced phosphorylation of protein S6
in liver disease is not causally related to the activity of
the protein synthesizing machinery.
Nevertheless the phosphorylation-dephosphorylation
cycle of S6 may well act as a translational control
mechanism (55—59) since it might condition the binding
to or release from the 40 S subunit of certain species of
mRNA (60). Accordingly structural changes of S6 would
regulate, in a qualitative manner, the formation of the
initiation complex, and thus the pattern of proteins
synthesized.
The hypothesis is supported indirectly by recent results,
which suggest the involvement of the ribosome in the
control of protein synthesis (56). In this respect it would
be of interest to learn whether the translation of individ-
ual mRNAs is differentially inhibited or amplified in
injured liver cells. The question is of practical importance
since it has been proposed that disease-induced changes
in the profile of proteins synthesized might be more
critical for the loss of liver cell integrity than an uniform
shut down of general protein synthesis (61).
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